Skip to main content

Advertisement

SpringerLink
Log in

Spectrum of the prostate lesions with increased FDG uptake on 18F-FDG PET/CT

  • Pictorial Essay
  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

Objective

Increased FDG uptake in the prostate can be caused by both benign and malignant conditions. The purpose of this pictorial review is to demonstrate a spectrum of prostate lesions which can show increased FDG uptake on PET/CT imaging.

Conclusion

Various prostate lesions can show increased FDG uptake. Knowledge of the uptake characteristics of these lesions may be helpful for increasing diagnostic accuracy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15

Similar content being viewed by others

References

  1. Hwang I, Chong A, Jung SI, et al. (2013) Is further evaluation needed for incidental focal uptake in the prostate in 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography images? Ann Nucl Med 27:140–145

    Article  PubMed  Google Scholar 

  2. Sayed MH, Farghaly HR, Nguyen NC, et al. (2010) Interesting image. Extrapulmonary small cell carcinoma in prostate: detection with F-18 FDG PET/CT. Clin Nucl Med 35:38–39

    Article  PubMed  Google Scholar 

  3. Yilmaz M, Celen Z, Sevinc A, Karakok M (2009) Widespread metastases in small cell carcinoma of the prostate on FDG PET/CT. Clin Nucl Med 34:598–600

    Article  PubMed  Google Scholar 

  4. de Carvalho Flamini R, Yamaga L, Mello ME, et al. (2010) F-18 FDG PET/CT imaging in small cell prostate cancer. Clin Nucl Med 35:452–453

    Article  Google Scholar 

  5. Ho L, Quan V, Henderson R, Seto J (2007) High-grade urothelial carcinoma of the prostate on FDG PET-CT. Clin Nucl Med 32:746–747

    Article  PubMed  Google Scholar 

  6. Komura K, Inamoto T, Tsuji M, et al. (2010) Basal cell carcinoma of the prostate: unusual subtype of prostatic carcinoma. Int J Clin Oncol 15:594–600

    Article  PubMed  Google Scholar 

  7. Wong CS, Chu YC, Khong PL (2011) Unusual features of gastrointestinal stromal tumor on PET/CT and CT imaging. Clin Nucl Med 36:e1–e7

    Article  PubMed  Google Scholar 

  8. Solis V, Rosenberg RJ, Spencer RP (2005) B cell lymphoma: a case with localized involvement of the prostate on F-18-FDG examination. Clin Nucl Med 30:236–237

    Article  PubMed  Google Scholar 

  9. Chang JM, Lee HJ, Lee SE, et al. (2008) Pictorial review: unusual tumours involving the prostate: radiological-pathological findings. Br J Radiol 81:907–915

    Article  CAS  PubMed  Google Scholar 

  10. Varghese SL, Grossfeld GD (2000) The prostatic gland: malignancies other than adenocarcinomas. Radiol Clin North Am 38:179–202

    Article  CAS  PubMed  Google Scholar 

  11. Humphrey PA (2010) Histological variants of prostatic carcinoma and their significance. Histopathology 60:59–74

    Article  Google Scholar 

  12. Kessler B, Albertsen P (2003) The natural history of prostate cancer. Urol Clin North Am 30:219–226

    Article  PubMed  Google Scholar 

  13. Kumar R, Zhuang H, Alavi A (2004) PET in the management of urologic malignancies. Radiol Clin North Am 42:1141–1153

    Article  PubMed  Google Scholar 

  14. Oyama N, Akino H, Suzuki Y, et al. (1999) The increased accumulation of [18F]fluorodeoxyglucose in untreated prostate cancer. Jpn J Clin Oncol 29:623–629

    Article  CAS  PubMed  Google Scholar 

  15. Effert P, Beniers AJ, Tamimi Y, Handt S, Jakse G (2004) Expression of glucose transporter 1 (Glut-1) in cell lines and clinical specimens from human prostate adenocarcinoma. Anticancer Res 24:3057–3063

    CAS  PubMed  Google Scholar 

  16. Liu IJ, Zafar MB, Lai YH, Segall GM, Terris MK (2001) Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer. Urology 57:108–111

    Article  CAS  PubMed  Google Scholar 

  17. Sung J, Espiritu JI, Segall GM, Terris MK (2003) Fluorodeoxyglucose positron emission tomography studies in the diagnosis and staging of clinically advanced prostate cancer. BJU Int 92:24–27

    Article  CAS  PubMed  Google Scholar 

  18. Shreve PD, Grossman HB, Gross MD, Wahl RL (1996) Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-d-glucose. Radiology 199:751–756

    CAS  PubMed  Google Scholar 

  19. Barloon TJ, Foderaro AE, Kramolowsky EV (1988) Giant prostate carcinoma: computed tomography findings and review of previous reports. J Comput Tomogr 12:49–53

    Article  CAS  PubMed  Google Scholar 

  20. Njinou Ngninkeu B, Lorge F, Moulin P, Jamart J, Van Cangh PJ (2003) Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases. J Urol 169:149–152

    Article  CAS  PubMed  Google Scholar 

  21. Patil VV, Wang ZJ, Sollitto RA, et al. (2009) 18F-FDG PET/CT of transitional cell carcinoma. AJR Am J Roentgenol 193:W497–W504

    Article  PubMed  Google Scholar 

  22. Jadvar H, Quan V, Henderson RW, Conti PS (2008) [F-18]-Fluorodeoxyglucose PET and PET-CT in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma. Int J Clin Oncol 13:42–47

    Article  PubMed Central  PubMed  Google Scholar 

  23. Kanthan R, Torkian B (2004) Squamous cell carcinoma of the prostate. A report of 6 cases. Urol Int 72:28–31

    Article  CAS  PubMed  Google Scholar 

  24. Nabi G, Ansari MS, Singh I, Sharma MC, Dogra PN (2001) Primary squamous cell carcinoma of the prostate: a rare clinicopathological entity. Report of 2 cases and review of literature. Urol Int 66:216–219

    Article  CAS  PubMed  Google Scholar 

  25. Suzawa N, Ito M, Qiao S, et al. (2011) Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour size. Lung Cancer 72:191–198

    Article  PubMed  Google Scholar 

  26. Imperiale A, Cimarelli S, Brigand C, et al. (2011) Does the association of 18F-FDG uptake intensity and lesion topography reveal histological phenotype and tumor differentiation in esophageal cancer? Hell J Nucl Med 14:239–242

    PubMed  Google Scholar 

  27. Dong A, Zuo C, Lu J, Wang Y (2013) Squamous cell carcinoma of the prostate with strong FDG uptake on PET/CT. Clin Nucl Med. doi:10.1097/RLU.0b013e31829af937

    Google Scholar 

  28. Begnami MD, Quezado M, Pinto P, Linehan WM, Merino M (2007) Adenoid cystic/basal cell carcinoma of the prostate: review and update. Arch Pathol Lab Med 131:637–640

    PubMed  Google Scholar 

  29. Ayyathurai R, Civantos F, Soloway MS, Manoharan M (2007) Basal cell carcinoma of the prostate: current concepts. BJU Int 99:1345–1349

    Article  PubMed  Google Scholar 

  30. Ali TZ, Epstein JI (2007) Basal cell carcinoma of the prostate: a clinicopathologic study of 29 cases. Am J Surg Pathol 31:697–705

    Article  PubMed  Google Scholar 

  31. Terris MK (1999) The appearance of adenoid cystic carcinoma of the prostate on transrectal ultrasonography. BJU Int 83:875–876

    Article  CAS  PubMed  Google Scholar 

  32. Segawa N, Tsuji M, Nishida T, et al. (2008) Basal cell carcinoma of the prostate: report of a case and review of the published reports. Int J Urol 15:557–559

    Article  PubMed  Google Scholar 

  33. Song YS, Lee WW, Chung JH, et al. (2008) Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung. Lung Cancer 61:54–60

    Article  PubMed  Google Scholar 

  34. Chong S, Lee KS, Kim BT, et al. (2007) Integrated PET/CT of pulmonary neuroendocrine tumors: diagnostic and prognostic implications. Am J Roentgenol 188:1223–1231

    Article  Google Scholar 

  35. Kamel EM, Zwahlen D, Wyss MT, et al. (2003) Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer. J Nucl Med 44:1911–1917

    PubMed  Google Scholar 

  36. Gregory DL, Brennan SM, Stillie A, et al. (2010) Impact of 18-F-fluorodeoxyglucose positron emission tomography in the staging and treatment response assessment of extra-pulmonary small-cell cancer. J Med Imaging Radiat Oncol 54:100–107

    Article  CAS  PubMed  Google Scholar 

  37. Dong A, Zuo C, Wang Y (2013) FDG PET/CT imaging of extrapulmonary small cell carcinoma of the adrenal gland. Clin Nucl Med 38:e407–e410

    Article  PubMed  Google Scholar 

  38. Paner GP, Aron M, Hansel DE, Amin MB (2012) Non-epithelial neoplasms of the prostate. Histopathology 60:166–186

    Article  PubMed  Google Scholar 

  39. Gaudin PB, Rosai J, Epstein JI (1998) Sarcomas and related proliferative lesions of specialized prostatic stroma: a clinicopathologic study of 22 cases. Am J Surg Pathol 22:148–162

    Article  CAS  PubMed  Google Scholar 

  40. Herawi M, Epstein JI (2006) Specialized stromal tumors of the prostate: a clinicopathologic study of 50 cases. Am J Surg Pathol 30:694–704

    Article  PubMed  Google Scholar 

  41. Hansel DE, Herawi M, Montgomery E, Epstein JI (2007) Spindle cell lesions of the adult prostate. Mod Pathol 20:148–158

    Article  CAS  PubMed  Google Scholar 

  42. Cheville JC, Dundore PA, Nascimento AG, et al. (1995) Leiomyosarcoma of the prostate. Report of 23 cases. Cancer 76:1422–1427

    Article  CAS  PubMed  Google Scholar 

  43. Sexton WJ, Lance RE, Reyes AO, et al. (2001) Adult prostate sarcoma: the MD Anderson Cancer Center experience. J Urol 166:521–525

    Article  CAS  PubMed  Google Scholar 

  44. Vandoros GP, Manolidis T, Karamouzis MV, et al. (2008) Leiomyosarcoma of the prostate: case report and review of 54 previously published cases. Sarcoma 2008:458709

    Article  PubMed Central  PubMed  Google Scholar 

  45. Charest M, Hickeson M, Lisbona R, et al. (2009) FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases. Eur J Nucl Med Mol Imaging 36:1944–1951

    Article  PubMed  Google Scholar 

  46. Punt SE, Eary JF, O’Sullivan J, Conrad EU (2009) Fluorodeoxyglucose positron emission tomography in leiomyosarcoma: imaging characteristics. Nucl Med Commun 30:546–549

    Article  PubMed Central  PubMed  Google Scholar 

  47. Agrons GA, Wagner BJ, Lonergan GJ, Dickey GE, Kaufman MS (1997) From the archives of the AFIP. Genitourinary rhabdomyosarcoma in children: radiologic-pathologic correlation. Radiographics 17:919–937

    Article  CAS  PubMed  Google Scholar 

  48. Parham DM (2001) Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol 14:506–514

    Article  CAS  PubMed  Google Scholar 

  49. Bisceglia M, Magro G, Carosi I, Cannazza V, Ben Dor D (2011) Primary embryonal rhabdomyosarcoma of the prostate in adults: report of a case and review of the literature. Int J Surg Pathol 19:831–837

    Article  PubMed  Google Scholar 

  50. Tateishi U, Hosono A, Makimoto A, et al. (2009) Comparative study of FDG-PET/CT and conventional imaging in the staging of rhabdomyosarcoma. Ann Nucl Med 23:155–161

    Article  PubMed  Google Scholar 

  51. Al-Agha OM, Igbokwe AA (2008) Malignant fibrous histiocytoma: between the past and the present. Arch Pathol Lab Med 132:1030–1035

    PubMed  Google Scholar 

  52. Kransdorf MJ (1995) Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. Am J Roentgenol 164:129–134

    Article  CAS  Google Scholar 

  53. Aoki J, Watanabe H, Shinozaki T, et al. (2003) FDG-PET for preoperative differential diagnosis between benign and malignant soft tissue masses. Skeletal Radiol 32:133–138

    Article  CAS  PubMed  Google Scholar 

  54. Coffin CM, Dehner LP (1989) Peripheral neurogenic tumors of the soft tissues in children and adolescents: a clinicopathologic study of 139 cases. Pediatr Pathol 9:387–407

    Article  CAS  PubMed  Google Scholar 

  55. Jürgens H, Bier V, Harms D, et al. (1988) Malignant peripheral neuroectodermal tumors. A retrospective analysis of 42 patients. Cancer 61:349–357

    Article  PubMed  Google Scholar 

  56. Györke T, Zajic T, Lange A, et al. (2006) Impact of FDG-PET for staging of Ewing sarcomas and primitive neuroectodermal tumours. Nucl Med Commun 27:17–24

    Article  PubMed  Google Scholar 

  57. Meltzer CC, Townsend DW, Kottapally S, Jadali F (1998) FDG imaging of spinal cord primitive neuroectodermal tumor. J Nucl Med 39:1207–1209

    CAS  PubMed  Google Scholar 

  58. Dong A, Wang Y, Lu J, Zuo C (2013) FDG PET/CT in peripheral primitive neuroectodermal tumor of the retroperitoneum. Clin Nucl Med. doi:10.1097/RLU.0b013e318292f38e

    Google Scholar 

  59. Aras M, Dede F, Dane F, Aktas B, Turoglu HT (2013) FDG PET/CT appearance of portal vein tumor thrombus in the gastric primitive neuroectodermal tumor: uncommon primary tumor site with rare finding. Clin Nucl Med 38:47–49

    Article  PubMed  Google Scholar 

  60. Watanabe N, Kawano M, Takada M, et al. (2006) F-18 FDG-PET imaging in a primitive neuroectodermal tumor. Clin Nucl Med 31:484–485

    Article  PubMed  Google Scholar 

  61. Musana KA, Raja S, Cangelosi CJ, Lin YG (2006) FDG PET scan in a primitive neuroectodermal tumor. Ann Nucl Med 20:221–225

    Article  PubMed  Google Scholar 

  62. Jun L, Ke S, Zhaoming W, Linjie X, Xinru Y (2008) Primary synovial sarcoma of the prostate: report of 2 cases and literature review. Int J Surg Pathol 16:329–334

    Article  PubMed  Google Scholar 

  63. Murphey MD, Gibson MS, Jennings BT, et al. (2006) From the archives of the AFIP: imaging of synovial sarcoma with radiologic-pathologic correlation. Radiographics 26:1543–1565

    Article  PubMed  Google Scholar 

  64. Ferrari A, Gronchi A, Casanova M, et al. (2004) Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution. Cancer 101:627–634

    Article  PubMed  Google Scholar 

  65. Lisle JW, Eary JF, O’Sullivan J, Conrad EU (2009) Risk assessment based on FDG-PET imaging in patients with synovial sarcoma. Clin Orthop Relat Res 467:1605–1611

    Article  PubMed Central  PubMed  Google Scholar 

  66. Gold JS, Antonescu CR, Hajdu C, et al. (2002) Clinicopathologic correlates of solitary fibrous tumors. Cancer 94:1057–1068

    Article  PubMed  Google Scholar 

  67. Herawi M, Epstein JI (2007) Solitary fibrous tumor on needle biopsy and transurethral resection of the prostate: a clinicopathologic study of 13 cases. Am J Surg Pathol 31:870–876

    Article  PubMed  Google Scholar 

  68. Moureau-Zabotto L, Chetaille B, Bladou F, et al. (2012) Solitary fibrous tumor of the prostate: case report and review of the literature. Case Rep Oncol 5:22–29

    Article  PubMed Central  PubMed  Google Scholar 

  69. Wakisaka N, Kondo S, Murono S, et al. (2009) A solitary fibrous tumor arising in the parapharyngeal space, with MRI and FDG-PET findings. Auris Nasus Larynx 36:367–371

    Article  PubMed  Google Scholar 

  70. Gorospe L (2012) Giant benign solitary fibrous tumor of the pleura: PET/CT findings. Clin Nucl Med 37:702–704

    Article  PubMed  Google Scholar 

  71. Migita K, Watanabe A, Nakagawa K, Ohyama T, Sekigawa S (2009) Solitary fibrous tumor of the abdominal wall. Int J Clin Oncol 14:555–559

    Article  PubMed  Google Scholar 

  72. Santambrogio L, Nosotti M, Palleschi A, et al. (2008) Solitary fibrous tumor of the pleura presenting with syncope episodes when coughing. World J Surg Oncol 6:86

    Article  PubMed Central  PubMed  Google Scholar 

  73. Yan J, Jones RL, Lewis DH, Eary JF (2013) Impact of (18)F-FDG-PET/CT imaging in therapeutic decisions for malignant solitary fibrous tumor of the pelvis. Clin Nucl Med 38:453–455

    Article  PubMed  Google Scholar 

  74. Miettinen M, Lasota J (2006) Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 23:70–83

    Article  PubMed  Google Scholar 

  75. Reith JD, Goldblum JR, Lyles RH, Weiss SW (2000) Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol 13:577–585

    Article  CAS  PubMed  Google Scholar 

  76. Basu S, Mohandas KM, Peshwe H, Asopa R, Vyawahare M (2008) FDG-PET and PET/CT in the clinical management of gastrointestinal stromal tumor. Nucl Med Commun 29:1026–1039

    Article  PubMed  Google Scholar 

  77. Park JW, Cho CH, Jeong DS, Chae HD (2011) Role of F-fluoro-2-deoxyglucose Positron Emission Tomography in Gastric GIST: Predicting Malignant Potential Pre-operatively. J Gastric Cancer 11:173–179

    Article  PubMed Central  PubMed  Google Scholar 

  78. Eslamy HK, Quon A (2008) PET/CT imaging of gastrointestinal stromal tumor with calcified peritoneal implants after imatinib therapy. Clin Nucl Med 33:864–865

    Article  PubMed  Google Scholar 

  79. Antoch G, Kanja J, Bauer S, et al. (2004) Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors. J Nucl Med 45:357–365

    CAS  PubMed  Google Scholar 

  80. Gong N, Wong CS, Chu YC (2011) Is lymph node metastasis a common feature of gastrointestinal stromal tumor? PET/CT correlation. Clin Nucl Med 36:678–682

    Article  PubMed  Google Scholar 

  81. Chu PG, Huang Q, Weiss LM (2005) Incidental and concurrent malignant lymphomas discovered at the time of prostatectomy and prostate biopsy: a study of 29 cases. Am J Surg Pathol 29:693–699

    Article  PubMed  Google Scholar 

  82. Bostwick DG, Iczkowski KA, Amin MB, Discigil G, Osborne B (1998) Malignant lymphoma involving the prostate: report of 62 cases. Cancer 83:732–738

    Article  CAS  PubMed  Google Scholar 

  83. Kwee TC, Kwee RM, Nievelstein RA (2008) Imaging in staging of malignant lymphoma: a systematic review. Blood 111:504–516

    Article  CAS  PubMed  Google Scholar 

  84. Hodgson R, Huang YT, Steinke K, Ravi Kumar AS (2010) FDG-PET/CT in evaluation and prognostication of primary prostate lymphoma. Clin Nucl Med 35:418–420

    Article  PubMed  Google Scholar 

  85. Li G, Dhawan M, Takalkar AM, Lilien DL (2011) FDG PET/CT imaging suggests lymphoma involving prostate may be more resistant to treatment. Clin Nucl Med 36:255–257

    Article  CAS  PubMed  Google Scholar 

  86. Cimarelli S, Lachenal F, Ricard F, et al. (2010) A case of advanced non-Hodgkin’s lymphoma involving the prostate: staging and treatment monitoring using F-18 FDG PET/CT imaging. Clin Nucl Med 35:425–427

    Article  PubMed  Google Scholar 

  87. Krieger JN, Nyberg L Jr, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282:236–237

    Article  CAS  PubMed  Google Scholar 

  88. Nishimori I, Kohsaki T, Onishi S, et al. (2007) IgG4-related autoimmune prostatitis: two cases with or without autoimmune pancreatitis. Intern Med 46:1983–1989

    Article  PubMed  Google Scholar 

  89. Yoshimura Y, Takeda S, Ieki Y, et al. (2006) IgG4-associated prostatitis complicating autoimmune pancreatitis. Intern Med 45:897–901

    Article  PubMed  Google Scholar 

  90. Uehara T, Hamano H, Kawakami M, et al. (2008) Autoimmune pancreatitis-associated prostatitis: distinct clinicopathological entity. Pathol Int 58:118–125

    Article  PubMed  Google Scholar 

  91. Stimac G, Reljic A, Spajic B, et al. (2009) Aggressiveness of inflammation in histological prostatitis–correlation with total and free prostate specific antigen levels in men with biochemical criteria for prostate biopsy. Scott Med J 54:8–12

    Article  CAS  PubMed  Google Scholar 

  92. Kao PF, Chou YH, Lai CW (2008) Diffuse FDG uptake in acute prostatitis. Clin Nucl Med 33:308–310

    Article  PubMed  Google Scholar 

  93. Arzola JM, Hawley JS, Oakman C, Mora RV (2007) A case of prostatitis due to Burkholderia pseudomallei. Nat Clin Pract Urol 4:111–114

    Article  PubMed  Google Scholar 

  94. Wilkinson C, Chowdhury F, Scarsbrook A, Smith J (2012) BCG-induced granulomatous prostatitis–an incidental finding on FDG-PET–CT. Clin Imaging 36:413–415

    Article  PubMed  Google Scholar 

  95. Ilgan S, Koca G, Gundogdu S (2009) Incidental detection of granulomatous prostatitis by F-18 FDG PET/CT in a patient with bladder cancer: a rare complication of BCG instillation therapy. Clin Nucl Med 34:613–614

    Article  PubMed  Google Scholar 

  96. Lin KH, Chen YS, Hu G, Tsay DG, Peng NJ (2010) Chronic bacterial prostatitis detected by FDG PET/CT in a patient presented with fever of unknown origin. Clin Nucl Med 35:894–895

    Article  PubMed  Google Scholar 

  97. Han EJ, HO J, Choi WH, Yoo IR, Chung SK (2010) Significance of incidental focal uptake in prostate on 18-fluoro-2-deoxyglucose positron emission tomography CT images. Br J Radiol 83:915–920

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  98. Almuhaideb A, Syed R, Iordanidou L, Saad Z, Bomanji J (2011) Fluorine-18-fluorodeoxyglucose PET/CT rare finding of a unique multiorgan involvement of Wegener’s granulomatosis. Br J Radiol 84:e202–e204

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  99. Zhang J, Shao C, Wang J, et al. (2012) (2013) Autoimmune pancreatitis: whole-body (18)F-FDG PET/CT findings. Abdom Imaging 38:543–549

    Article  Google Scholar 

Download references

Acknowledgments

Aisheng Dong was sponsored by Young Scholar Grant from National Natural Science Foundation of China (81000601). Changjing Zuo was sponsored by New Round of Shanghai Health System Excellent Discipline Leader Training Plan Fund (XBR2011040), Development Fund for Shanghai Talents (2010020), and Shanghai Postdoctoral Science Found (11R21410600).

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Yangpu District, Shanghai, 200433, China

    Aisheng Dong & Changjing Zuo

  2. Department of Orthopaedics Surgery, Changhai Hospital, Second Military Medical University, Shanghai, 200433, China

    Yushu Bai

  3. Department of Pathology, Changhai Hospital, Second Military Medical University, Shanghai, 200433, China

    Yang Wang

  4. Department of Radiology, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Yangpu District, Shanghai, 200433, China

    Jianping Lu

Authors
  1. Aisheng Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yushu Bai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Changjing Zuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jianping Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Changjing Zuo or Jianping Lu.

Additional information

Aisheng Dong and Yushu Bai have contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dong, A., Bai, Y., Wang, Y. et al. Spectrum of the prostate lesions with increased FDG uptake on 18F-FDG PET/CT. Abdom Imaging 39, 908–921 (2014). https://doi.org/10.1007/s00261-014-0114-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-014-0114-0

Keywords

Search

Navigation